Insider · CIK 0001759506

Vexler Vladimir

Reports to the SEC for 1 company · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001759506

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-31	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−16.3K sh	$6.84	−$111K	116,361
2023-01-20	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+40K sh	—	—	131,323
2023-01-11	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,602 sh	$10.26	−$37K	91,323
2023-01-10	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,602 sh	$9.85	−$35.5K	94,925
2023-01-04	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−5,437 sh	$9.87	−$53.7K	98,527
2023-01-04	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2022-04-01	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,458 sh	$12.85	−$44.4K	103,963
2022-01-11	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,583 sh	$14.36	−$51.5K	107,421
2022-01-10	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−4,150 sh	$14.30	−$59.3K	111,004
2022-01-04	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+40K sh	—	—	115,154
2022-01-04	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2021-04-28	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+20K sh	—	—	73,386
2021-03-09	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+24.4K sh	$2.08	+$50.8K	89,502
2021-03-09	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20.3K sh	$9.30	+$189K	109,814
2021-03-09	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+57.8K sh	$10.05	+$581K	167,626
2021-03-09	CHRSCoherus Oncology, Inc.S Sale	Chief Scientific Officer	SSale	−114K sh	$16.25	−$1.86M	53,386
2021-03-09	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−24.4K sh	—	—	0
2021-03-09	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20.3K sh	—	—	4,688
2021-03-09	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−57.8K sh	—	—	17,188
2021-02-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2021-01-11	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+31.3K sh	—	—	65,146
2021-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+62.5K sh	—	—	62,500
2021-01-10	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−4,080 sh	$18.18	−$74.2K	33,896
2020-12-10	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.6K sh	$2.08	+$36.7K	54,299
2020-12-10	CHRSCoherus Oncology, Inc.S Sale	Chief Scientific Officer	SSale	−17.6K sh	$18.05	−$318K	36,673
2020-12-10	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.6K sh	—	—	24,356
2020-12-09	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+30K sh	$2.08	+$62.5K	86,185
2020-12-09	CHRSCoherus Oncology, Inc.S Sale	Chief Scientific Officer	SSale	−49.5K sh	$18.24	−$903K	36,673
2020-12-09	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−30K sh	—	—	41,982
2020-01-10	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+8,900 sh	—	—	28,412
2020-01-10	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,477 sh	$17.73	−$61.6K	24,935
2020-01-10	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+31.3K sh	—	—	56,185
2020-01-10	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+62.5K sh	—	—	62,500
2019-01-11	CHRSCoherus Oncology, Inc.A Award	Chief Scientific Officer	AAward	+15.6K sh	—	—	23,390
2019-01-11	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−5,916 sh	$12.37	−$73.2K	17,474
2019-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+126K sh	—	—	126,000
2018-11-16	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+35K sh	—	—	35,000
2018-11-16	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+35K sh	—	—	35,000
2018-11-16	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Apr 44
Vexler Vladimir0001140361-23-016457
SEC(opens sec.gov)
Jan 244
Vexler Vladimir0001567619-23-001209
SEC(opens sec.gov)
Jan 124
Vexler Vladimir0001567619-23-000892
SEC(opens sec.gov)
Jan 64
Vexler Vladimir0001567619-23-000696
SEC(opens sec.gov)
Apr 54
Vexler Vladimir0001567619-22-008113
SEC(opens sec.gov)
Jan 124
Vexler Vladimir0001567619-22-001114
SEC(opens sec.gov)
Jan 64
Vexler Vladimir0001567619-22-000819
SEC(opens sec.gov)
Apr 304
Vexler Vladimir0001567619-21-008803
SEC(opens sec.gov)
Mar 114
Vexler Vladimir0001567619-21-006128
SEC(opens sec.gov)
Feb 34
Vexler Vladimir0001567619-21-002144
SEC(opens sec.gov)

Companies

Coherus Oncology, Inc.Chief Scientific OfficerCHRS

Address

COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065